A 62-year-old man with acute coronary syndrome (NSTEMI) presents to the emergency department 2 hours after symptom onset. He has no contraindications to antiplatelet therapy. Which of the following is the drug of choice for dual antiplatelet therapy in this setting?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.